Uveal melanoma epidemiology and demographics

Jump to navigation Jump to search

Uveal melanoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveal melanoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Uveal melanoma epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Uveal melanoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Uveal melanoma epidemiology and demographics

CDC on Uveal melanoma epidemiology and demographics

Uveal melanoma epidemiology and demographics in the news

Blogs on Uveal melanoma epidemiology and demographics

to Hospitals Treating Uveal melanoma

Risk calculators and risk factors for Uveal melanoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

The incidence of uveal melanoma in the United States is approximately 0.43 per 100,000 individuals. The majority of uveal melanoma cases are reported in Europe and United States. The incidence of uveal melanoma increases with age; the median age at diagnosis is 60 years. Males are more commonly affected with uveal melanoma than females. Uveal melanoma commonly affects individuals older than twenty years of age. Caucasians are more commonly affected with uveal melanoma than Africans.[1][2]

Epidemiology and Demographics

  • Uveal melanoma comprises approximately 5–12% of all melanomas. The choroid posterior to the equator, often referred to as the posterior choroid, is the most common site involved with nearly 85% of cases localized to this region. Anterior uveal melanoma involves the ciliary body, iris, and/or choroid anterior to the equator and comprises 9-15% of uveal melanomas.[3]
  • Melanoma localized to the iris and the ciliary body encompasses approximately 2-4% and 4-7% of uveal melanoma cases respectively.[4]
  • The incidence of uveal melanoma in Europe and United States is comparable to that in New Zealand and Australia. In Europe, a lower incidence is reported in the south of Italy and Spain, about 2 per million, whereas registries in France, the Netherlands, Germany and Switzerland has values around 4 to 5 per million. The United Kingdom registered over 6 per million cases of uveal melanoma, and the highest incidence is up to > 8 per million in Denmark and Norway. Uveal melanoma is less common in Asians.[1]
  • Approximately 2% of uveal melanomas are found in patients younger than 20 year of age.

Incidence

The incidence of uveal melanoma in the United States is approximately 0.43 per 100, 000 individuals. The incidence of uveal melanoma is approximately .53 to 1.09 cases per 100, 000 individuals worldwide. The incidence of uveal melanoma is approximately 1200–1500 new cases per year in the USA.[2]

Age

Uveal melanoma is diagnosed mostly at older ages, with a progressively rising, age-specific, incidence rate that peaks near the age of 70 years. Approximately 80% of the primary intraocular tumors are diagnosed as uveal melanoma in patients above the age of 20 years, and with a mean age of diagnosis of 60 years.[1]

Gender

Males are more commonly affected with uveal melanoma than females. The incidence of uveal melanoma in males and females is approximately 0.49 and 0.37 per 100,000 individuals respectively.[2]

Race

Caucasians are approximately 150 times more frequently affected with uveal melanoma than Africans.[1]

References

  1. 1.0 1.1 1.2 1.3 van, J.G.M.; Koopmans, A.E.; Verdijk, R.M.; Naus, N.C.; de, A.; Kilic, E. (2013). "Diagnosis, Histopathologic and Genetic Classification of Uveal Melanoma". doi:10.5772/53631.
  2. 2.0 2.1 2.2 Uveal melanoma. National Cancer Institute(2015) http://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq Accessed on October 24 2015
  3. Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA (2012). "Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases". Retina. 32 (7): 1363–72. doi:10.1097/IAE.0b013e31824d09a8. PMID 22466491.
  4. Shields CL, Kaliki S, Shah SU, Luo W, Furuta M, Shields JA (2012). "Iris melanoma: features and prognosis in 317 children and adults". J AAPOS. 16 (1): 10–6. doi:10.1016/j.jaapos.2011.10.012. PMID [ 22370659 [ Check |pmid= value (help).

Template:WH Template:WS